The MYC Paralog-PARP1 Axis as a Potential TherapeuticTarget in MYC Paralog-Activated Small Cell Lung Cancer
文献类型:期刊论文
作者 | Bian, Xing1,2,3,4; Wang, Xiaolin1,2,3,4; Zhang, Qiuyan5; Ma, Liying1,2,3,4; Cao, Guozhen1,2,3,4; Xu, Ao6,7; Han, Jinhua8,9; Huang, Jun8,9; Lin, Wenchu1,3,4 |
刊名 | FRONTIERS IN ONCOLOGY |
出版日期 | 2020-10-08 |
卷号 | 10 |
ISSN号 | 2234-943X |
关键词 | small cell lung cancer MYCparalog PARP1 BET DNA damage response |
DOI | 10.3389/fonc.2020.565820 |
通讯作者 | Lin, Wenchu(wenchu@hmfl.ac.cn) |
英文摘要 | Poly (ADP-ribose) polymerase 1 (PARP1) is highly expressed in small cell lung cancer (SCLC) and has emerged as an attractive target for treatment of SCLC. However, the clinical significance of PARP1 expression in SCLC remains elusive. In this study, we showed that high PARP1 expression was associated with better overall survival (OS), and was positively correlated with the expression of MYC paralogs in patients with SCLC. We demonstrated that PARP1 was transcriptionally regulated by MYC paralogs. Integrative analysis of multiple RNA-seq data sets indicated that DNA damage response (DDR) genes involved in the replication stress response (RSR) and homologous recombination (HR) repair pathways were highly enriched in MYC paralog-addicted SCLC cell models and in human SCLC specimens. Targeting the MYC paralog-PARP1 axis with concomitant BET and PARP inhibition resulted in synergistic effects in MYC paralog-activated SCLC. Our study identified a critical PARP1 regulatory pathway, and provided evidence for a rational combination treatment strategy for MYC paralog-activated SCLC. |
WOS关键词 | PARP INHIBITORS ; DNA ; PATHWAY ; GENE ; MUTATIONS ; TARGETS ; STRESS ; DRIVEN |
资助项目 | National Natural Science Foundation of China[81972191] ; National Natural Science Foundation of China[81672647] ; Science and Technology Service Network Initiative of Chinese Academy of Sciences[KFJ-STS-SCYD-010] ; Science and Technology Major Project of Anhui Province[18030801140] ; Key program of 13th five-year plan of CASHIPS[KP-2017-26] ; 100-Talent Program of Chinese Academy of Sciences |
WOS研究方向 | Oncology |
语种 | 英语 |
出版者 | FRONTIERS MEDIA SA |
WOS记录号 | WOS:000580545700001 |
资助机构 | National Natural Science Foundation of China ; Science and Technology Service Network Initiative of Chinese Academy of Sciences ; Science and Technology Major Project of Anhui Province ; Key program of 13th five-year plan of CASHIPS ; 100-Talent Program of Chinese Academy of Sciences |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/104633] |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Lin, Wenchu |
作者单位 | 1.Chinese Acad Sci, High Field Magnet Lab, Hefei, Peoples R China 2.Univ Sci & Technol China, Hefei, Peoples R China 3.Chinese Acad Sci, Hefei Inst Phys Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei, Peoples R China 4.High Magnet Field Lab Anhui Prov, Hefei, Peoples R China 5.Univ Sci & Technol China, Sch Life Sci, Innovat Ctr Cell Signaling Network, CAS Key Lab Innate Immun & Chron Dis, Hefei, Peoples R China 6.Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp 1, Hefei, Peoples R China 7.Anhui Prov Hosp, Dept Pathol, Hefei, Peoples R China 8.Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Hangzhou, Peoples R China 9.Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Bian, Xing,Wang, Xiaolin,Zhang, Qiuyan,et al. The MYC Paralog-PARP1 Axis as a Potential TherapeuticTarget in MYC Paralog-Activated Small Cell Lung Cancer[J]. FRONTIERS IN ONCOLOGY,2020,10. |
APA | Bian, Xing.,Wang, Xiaolin.,Zhang, Qiuyan.,Ma, Liying.,Cao, Guozhen.,...&Lin, Wenchu.(2020).The MYC Paralog-PARP1 Axis as a Potential TherapeuticTarget in MYC Paralog-Activated Small Cell Lung Cancer.FRONTIERS IN ONCOLOGY,10. |
MLA | Bian, Xing,et al."The MYC Paralog-PARP1 Axis as a Potential TherapeuticTarget in MYC Paralog-Activated Small Cell Lung Cancer".FRONTIERS IN ONCOLOGY 10(2020). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。